| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.055 | 0.9 |